Abstract:Background Angiogenesis plays an important role in tumor growth and metastasis, therefore antiangiogenic therapy was widely investigated as a promising approach for cancer therapy. Recently, pigment epithelium-derived factor (PEDF) has been shown to be the most potent inhibitor of angiogenesis. Adeno-associated virus (AAV) vectors have been intensively studied due to their wide tropisms, nonpathogenicity, and long-term transgene expression in vivo . The objective of this work was to evaluate the ability of AAV-mediated human PEDF (hPEDF) as a potent tumor suppressor and a potential candidate for cancer gene therapy. Methods Recombinant AAV 2 encoding hPEDF (rAAV 2 -hPEDF) was constructed and produced, and then was assigned for in vitro and in vivo experiments. Conditioned medium from cells infected with rAAV 2 -hPEDF was used for cell proliferation and tube formation tests of human umbilical vein endothelial cells (HUVECs). Subsequently, colorectal peritoneal carcinomatosis (CRPC) mouse model was established and treated with rAAV 2 -hPEDF. Therapeutic efficacy of rAAV 2 -hPEDF were investigated, including tumor growth and metastasis, survival time, microvessel density (MVD) and apoptosis index of tumor tissues, and hPEDF levels in serum and ascites. Results rAAV 2 -hPEDF was successfully constructed, and transmission electron microscope (TEM) showed that rAAV 2 -hPEDF particles were non-enveloped icosahedral shape with a diameter of approximately 20 nm. rAAV 2 -hPEDF-infected cells expressed hPEDF protein, and the conditioned medium from infected cells inhibited proliferation and tube-formation of HUVECs in vitro . Furthermore, in CRPC mouse model, rAAV 2 -hPEDF significantly suppressed tumor growth and metastasis, and prolonged survival time of treated mice. Immunofluorescence studies indicated that rAAV 2 -hPEDF could inhibit angiogenesis and induce apoptosis in tumor tissues. Besides, hPEDF levels in serum and ascites of rAAV 2 -hPEDF-treated mice were significant higher than those in rAAV 2 -null or normal saline (NS) groups. Conclusions Thus, our results suggest that rAAV 2 -hPEDF may be a potential candidate as an antiangiogenic therapy agent.

Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration

The Pigment Epithelial-Derived Factor Gene Loaded in PLGA Nanoparticles for Therapy of Colon Carcinoma.

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Anti-EGF Antibody Cationic Polymeric Liposomes for Delivery of the P53 Gene for Ovarian Carcinoma Therapy

Polydopamine-based Nanoparticles with Excellent Biocompatibility for Photothermally Enhanced Gene Delivery

Pigment epithelium-derived factor gene loaded in cRGD–PEG–PEI suppresses colorectal cancer growth by targeting endothelial cells

Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression

Promising Nanocarriers for PEDF Gene Targeting Delivery to Cervical Cancer Cells Mediated by the Over-expressing FRα

Combined Tumor- and Neovascular-"Dual Targeting" Gene/Chemo-Therapy Suppresses Tumor Growth and Angiogenesis.

AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis model

DOTAP-Incorporated PEG-PLGA Nanoparticles for Efficient in Vitro and in Vivo Gene Delivery.

Polyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.

Functional study of dextran-graft-poly((2-dimethyl amino)ethyl methacrylate) gene delivery vector for tumor therapy.

Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma

Systemically Administered Liposome-Encapsulated Ad-PEDF Potentiates the Anti-Cancer Effects in Mouse Lung Metastasis Melanoma

Polydopamine nanoparticles with different sizes for NIR-promoted gene delivery and synergistic photothermal therapy

A Versatile Endosome Acidity-Induced Sheddable Gene Delivery System: Increased Tumor Targeting and Enhanced Transfection Efficiency

Polyethylene Glycol-Modified Pigment Epithelial-Derived Factor: New Prospects for Treatment of Retinal Neovascularization

Arginine-rich Peptide Based Nanoparticles with Bridge-Like Structure: Enhanced Cell Penetration and Tumor Therapy Effect

Multifunctional Amphiphilic Peptide Dendrimer As Nonviral Gene Vectors for Effective Cancer Therapy Via Combined Gene/photodynamic Therapies

Construction of a Star-Shaped Copolymer As a Vector for FGF Receptor-Mediated Gene Delivery in Vitro and in Vivo.